Autolus Therapeutics Scheduled to Report Q3 2026 Earnings on November 10
Autolus Therapeutics (AUTL) is set to release its third-quarter 2026 financial results on Tuesday, November 10, prior to the market opening. The company's performance is being closely watched as it prepares to report significant year-over-year growth in both top and bottom lines. Market consensus estimates project a revenue of $40.03 million, representing an 89.4% increase compared to the previous year. Additionally, earnings per share (EPS) are expected to be -$0.17, which marks a 43.3% improvement on a year-over-year basis.
Tickers: $AUTL
Topics: earnings release EPS estimates revenue estimates
Read the full article at Seeking Alpha
Part of the story Broadridge Financial Solutions Scheduled to Report Q1 2027 Earnings (21 articles)